Geron appoints Dawn C. Bir as Interim CEO, approves $750K salary and 180K option award

GERON CORP

Dr. Scarlett departed as President, CEO and Chairman on March 10; stays as employee through March 31.
Dawn C. Bir, Board member since 2019, named Interim President & CEO effective March 10, 2025.
Bir receives annual base salary of $750,000; option to purchase 180,000 shares under 2018 EIP.
Option vests on earlier of first anniversary of 2025 Annual Meeting date or next annual meeting.
Bir not eligible for incentive bonus or severance plan during interim role.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

John A. Scarlett

President, Chief Executive Officer and Chairman

GERN · GERON CORP

Effective: 2025-03-10
Successor: Dawn C. Bir
Filed: March 17, 2025, 7:59 PM ET

Effective March 10, 2025, the service of John A. Scarlett, M.D. as the President, Chief Executive Officer and Chairman of the Board of Directors (the “Board”) of Geron Corporation (the “Company” or “Geron”) concluded and, in connection therewith, Dr. Scarlett resigned from the Board.

Appointed

Elizabeth G. O'Farrell

Chair of the Board

GERN · GERON CORP

Effective: 2025-03-10
Filed: March 17, 2025, 7:59 PM ET

In addition, effective March 10, 2025, Ms. Elizabeth G. O’Farrell, currently the Lead Independent Director of the Board, was appointed Chair of the Board.

Appointed (interim)

Dawn C. Bir

Interim President and Chief Executive Officer

GERN · GERON CORP

Effective: 2025-03-10
Filed: March 17, 2025, 7:59 PM ET

Also, effective March 10, 2025, Dawn C. Bir, a current member of the Board, was appointed as the Interim President and Chief Executive Officer of Geron

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

John A. Scarlett resigned as President, Chief Executive Officer and Chairman at GERON CORP.

Action: resigned
Role: President, Chief Executive Officer and Chairman

Exact text from the filing

Effective March 10, 2025, the service of John A. Scarlett, M.D. as the President, Chief Executive Officer and Chairman of the Board of Directors (the “Board”) of Geron Corporation (the “Company” or “Geron”) concluded and, in connection therewith, Dr. Scarlett resigned from the Board.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Elizabeth G. O'Farrell was appointed as Chair of the Board at GERON CORP.

Action: appointed
Role: Chair of the Board

Exact text from the filing

In addition, effective March 10, 2025, Ms. Elizabeth G. O’Farrell, currently the Lead Independent Director of the Board, was appointed Chair of the Board.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Dawn C. Bir was appointed as Interim President and Chief Executive Officer at GERON CORP.

Action: appointed
Role: Interim President and Chief Executive Officer

Exact text from the filing

Also, effective March 10, 2025, Dawn C. Bir, a current member of the Board, was appointed as the Interim President and Chief Executive Officer of Geron

View on SEC.gov

GERON CORP filing history →

Source: SEC EDGAR

accession 0000950170-25-040247

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.